303 related articles for article (PubMed ID: 18267956)
1. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells.
Mahadev K; Wu X; Donnelly S; Ouedraogo R; Eckhart AD; Goldstein BJ
Cardiovasc Res; 2008 May; 78(2):376-84. PubMed ID: 18267956
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin inhibits palmitate-induced apoptosis through suppression of reactive oxygen species in endothelial cells: involvement of cAMP/protein kinase A and AMP-activated protein kinase.
Kim JE; Song SE; Kim YW; Kim JY; Park SC; Park YK; Baek SH; Lee IK; Park SY
J Endocrinol; 2010 Oct; 207(1):35-44. PubMed ID: 20675307
[TBL] [Abstract][Full Text] [Related]
3. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells.
Chen YJ; Zhang LQ; Wang GP; Zeng H; Lü B; Shen XL; Jiang ZP; Chen FP
Thromb Haemost; 2008 Aug; 100(2):291-300. PubMed ID: 18690350
[TBL] [Abstract][Full Text] [Related]
5. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.
Rousseau S; Houle F; Landry J; Huot J
Oncogene; 1997 Oct; 15(18):2169-77. PubMed ID: 9393975
[TBL] [Abstract][Full Text] [Related]
6. Xanthine oxidase interaction with vascular endothelial growth factor in human endothelial cell angiogenesis.
Kou B; Ni J; Vatish M; Singer DR
Microcirculation; 2008 Apr; 15(3):251-67. PubMed ID: 18386220
[TBL] [Abstract][Full Text] [Related]
7. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species.
Michaud SE; Dussault S; Groleau J; Haddad P; Rivard A
J Mol Cell Cardiol; 2006 Aug; 41(2):275-84. PubMed ID: 16806264
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
[TBL] [Abstract][Full Text] [Related]
9. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells: evidence for involvement of a cAMP signaling pathway.
Ouedraogo R; Wu X; Xu SQ; Fuchsel L; Motoshima H; Mahadev K; Hough K; Scalia R; Goldstein BJ
Diabetes; 2006 Jun; 55(6):1840-6. PubMed ID: 16731851
[TBL] [Abstract][Full Text] [Related]
11. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation.
Yamaoka-Tojo M; Ushio-Fukai M; Hilenski L; Dikalov SI; Chen YE; Tojo T; Fukai T; Fujimoto M; Patrushev NA; Wang N; Kontos CD; Bloom GS; Alexander RW
Circ Res; 2004 Aug; 95(3):276-83. PubMed ID: 15217908
[TBL] [Abstract][Full Text] [Related]
12. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II type 2 receptor inhibits vascular endothelial growth factor-induced migration and in vitro tube formation of human endothelial cells.
Benndorf R; Böger RH; Ergün S; Steenpass A; Wieland T
Circ Res; 2003 Sep; 93(5):438-47. PubMed ID: 12881481
[TBL] [Abstract][Full Text] [Related]
14. Role of afadin in vascular endothelial growth factor- and sphingosine 1-phosphate-induced angiogenesis.
Tawa H; Rikitake Y; Takahashi M; Amano H; Miyata M; Satomi-Kobayashi S; Kinugasa M; Nagamatsu Y; Majima T; Ogita H; Miyoshi J; Hirata K; Takai Y
Circ Res; 2010 Jun; 106(11):1731-42. PubMed ID: 20413783
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin inhibits insulin-like growth factor-1-induced cell migration by the suppression of extracellular signal-regulated kinase 1/2 activation, but not Akt in vascular smooth muscle cells.
Motobayashi Y; Izawa-Ishizawa Y; Ishizawa K; Orino S; Yamaguchi K; Kawazoe K; Hamano S; Tsuchiya K; Tomita S; Tamaki T
Hypertens Res; 2009 Mar; 32(3):188-93. PubMed ID: 19262481
[TBL] [Abstract][Full Text] [Related]
16. The farnesyltransferase inhibitor LB42708 suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signal pathways.
Kim CK; Choi YK; Lee H; Ha KS; Won MH; Kwon YG; Kim YM
Mol Pharmacol; 2010 Jul; 78(1):142-50. PubMed ID: 20406854
[TBL] [Abstract][Full Text] [Related]
17. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
Nakabayashi M; Morishita R; Nakagami H; Kuba K; Matsumoto K; Nakamura T; Tano Y; Kaneda Y
Diabetologia; 2003 Jan; 46(1):115-23. PubMed ID: 12637990
[TBL] [Abstract][Full Text] [Related]
18. Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K/Akt/eNOS signaling.
Namkoong S; Kim CK; Cho YL; Kim JH; Lee H; Ha KS; Choe J; Kim PH; Won MH; Kwon YG; Shim EB; Kim YM
Cell Signal; 2009 Jun; 21(6):906-15. PubMed ID: 19385062
[TBL] [Abstract][Full Text] [Related]
19. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Simioni C; Leung E; Maclennan S; Baraldi PG; Borea PA
Mol Pharmacol; 2007 Aug; 72(2):395-406. PubMed ID: 17488804
[TBL] [Abstract][Full Text] [Related]
20. FHL-2 suppresses VEGF-induced phosphatidylinositol 3-kinase/Akt activation via interaction with sphingosine kinase-1.
Hayashi H; Nakagami H; Takami Y; Koriyama H; Mori M; Tamai K; Sun J; Nagao K; Morishita R; Kaneda Y
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):909-14. PubMed ID: 19325137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
